Healthcare & life sciences coverage

chapter 11 and restructuring coverage across Healthcare & life sciences.

108 articles

Showing 73 to 84 of 108 coverage articles

Week of March 2, 2026

Mar 6

Exactech Files Chapter 11 to Separate Recall Liability Into Trust and Sell Going-Concern Business

Exactech Oct 2024 Delaware ch. 11 pursued an RSA-backed going-concern 363 sale process funded by an $85M DIP.

PrenegotiatedHealthcare & life sciences

Mar 6

Biora Therapeutics: 363 Sale Followed by Chapter 7 Conversion

Biora Therapeutics Dec 2024 Delaware ch. 11 ran an expedited 363 sale and later converted to ch. 7 in May 2025.

Chapter 7Healthcare & life sciences

Mar 6

Acorda Therapeutics Sells Assets to Merz for $185 Million, Liquidating Plan Confirmed

Acorda Therapeutics April 2024 SDNY ch. 11 ran a $185M stalking horse 363 sale to Merz and confirmed a liquidation plan.

Healthcare & life sciences

Mar 6

Cutera: Noteholders Convert $400M in Notes to Equity in 57-Day Prepackaged Case

Cutera's prepackaged chapter 11 converted $429M in unsecured senior notes to equity in 57 days, eliminating over $400M of debt. The Southern District of Texas case confirmed on day 42 over a U.S. Trustee release objection; Cutera emerged private on May 1, 2025.

PrepackagedConsumer & retail

Mar 6

Bedmar, LLC: Delaware Two-Step Dismissed in 81-Day Bad Faith Filing

Bedmar, LLC Judge Stickles dismissed after 81 days, ruling Delaware Two-Step lacked good faith. $372M claims to $33M cap failed.

PrepackagedHealthcare & life sciences

Mar 6

Partners Pharmacy: Loan-to-Own Restructuring in the LTC Pharmacy Sector

Partners Pharmacy: 83-day chapter 11; third-largest LTC pharmacy acquired via $51M credit bid in a loan-to-own deal.

Healthcare & life sciences

Mar 6

ModivCare: Largest NEMT Provider Cuts $1.1 Billion Debt in 117-Day Restructuring

ModivCare emerged from chapter 11 in 117 days after reducing $1.4B debt by 85%; nation's largest NEMT provider recapitalized.

PrepackagedHealthcare & life sciences

Mar 6

LifeScan Global: OneTouch Maker's 104-Day Chapter 11 Pivot to CGM Future

LifeScan eliminated $1.4B debt via prearranged chapter 11, emerging under Canyon Partners ownership; confirmation in 104 days.

PrenegotiatedHealthcare & life sciences

Mar 6

Apple Tree Files Chapter 11 to Halt $6.5B Fund Fight With Rybolovlev

Apple Tree Life Sciences filed Chapter 11 to preserve its $6.5B biotech fund amid a governance and funding dispute with Dmitry Rybolovlev's Rigmora.

FreefallHealthcare & life sciences

Mar 6

Lutheran Life Communities: $189M Bond Restructuring Tests CCRC Model

Lutheran Life Communities, a nonprofit CCRC operator serving 825 residents across four Illinois and Indiana facilities, filed chapter 11 to restructure $189M in municipal bonds via bondholder-negotiated exchange. The case highlights systemic CCRC sector vulnerability to post-pandemic economics.

FreefallHealthcare & life sciences

Mar 6

Omega Therapeutics: $14M Chapter 11 Sale After $532M Deal

Clinical-stage biotech Omega Therapeutics filed chapter 11 in Delaware Feb 2025 after Banc of California swept $14.7M from accounts. Flagship Pioneering affiliate acquired all assets via $14M credit bid in 74 days. Plan of liquidation confirmed July 2025.

Healthcare & life sciences

Mar 6

Georgia ProtonCare Center Inc.: Emory Leads $110M Sale

Georgia ProtonCare Center filed chapter 11 in N.D. Georgia to sell its Midtown Atlanta proton therapy center, led by Emory’s $110 million stalking horse bid.

FreefallHealthcare & life sciences

9